| PTIX Stock | | | USD 0.73 0.08 12.31% |
Protagenic Therapeutics financial indicator trend analysis is much more than just breaking down Protagenic Therapeutics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Protagenic Therapeutics is a good investment. Please check the relationship between Protagenic Therapeutics Cash And Short Term Investments and its Total Current Liabilities accounts. Check out
Your Equity Center to better understand how to build diversified portfolios, which includes a position in Protagenic Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in gross domestic product.
For more information on how to buy Protagenic Stock please use our
How to Invest in Protagenic Therapeutics guide.
Cash And Short Term Investments vs Total Current Liabilities
Cash And Short Term Investments vs Total Current Liabilities Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Protagenic Therapeutics Cash And Short Term Investments account and
Total Current Liabilities. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Protagenic Therapeutics' Cash And Short Term Investments and Total Current Liabilities is -0.11. Overlapping area represents the amount of variation of Cash And Short Term Investments that can explain the historical movement of Total Current Liabilities in the same time period over historical financial statements of Protagenic Therapeutics, assuming nothing else is changed. The correlation between historical values of Protagenic Therapeutics' Cash And Short Term Investments and Total Current Liabilities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash And Short Term Investments of Protagenic Therapeutics are associated (or correlated) with its Total Current Liabilities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Liabilities has no effect on the direction of Cash And Short Term Investments i.e., Protagenic Therapeutics' Cash And Short Term Investments and Total Current Liabilities go up and down completely randomly.
Correlation Coefficient | -0.11 |
| Relationship Direction | Negative |
| Relationship Strength | Insignificant |
Cash And Short Term Investments
Short Term Investments is an account in the current assets section of Protagenic Therapeutics balance sheet. This account contains Protagenic Therapeutics investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Protagenic Therapeutics fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.
Total Current Liabilities
Total Current Liabilities is an item on Protagenic Therapeutics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Protagenic Therapeutics are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.
Most indicators from Protagenic Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Protagenic Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Your Equity Center to better understand how to build diversified portfolios, which includes a position in Protagenic Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in gross domestic product.
For more information on how to buy Protagenic Stock please use our
How to Invest in Protagenic Therapeutics guide.
Selling General Administrative is likely to drop to about 1.1
M in 2024.
Issuance Of Capital Stock is expected to grow at the current pace this year
Protagenic Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Protagenic Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Protagenic Therapeutics fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Protagenic Stock Analysis
When running Protagenic Therapeutics' price analysis, check to
measure Protagenic Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protagenic Therapeutics is operating at the current time. Most of Protagenic Therapeutics' value examination focuses on studying past and present price action to
predict the probability of Protagenic Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protagenic Therapeutics' price. Additionally, you may evaluate how the addition of Protagenic Therapeutics to your portfolios can decrease your overall portfolio volatility.